Estelle Torbey

Dr. Estelle Torbey


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2013 in Annals of Surgical Innovation and Research
Verified
Journal Article
Open access
PDF file
NHNicholas Habib
Nicholas Habib
SHSamer Hassan
Samer Hassan
RARafik Abdou
Rafik Abdou
ETEstelle Torbey
Estelle Torbey
HAHomam Alkaied
Homam Alkaied
Kassem HarrisKassem Harris
Kassem Harris
Gastroduodenal artery (GDA) aneurysms are rare but a potentially fatal condition if rupture occurs. They represent about 1.5% of all visceral artery (VAA) aneurysms and are divided into true and pseudoaneurysms depending on the etiologic factors underlying their development. Atherosclerosis and pancreatitis are the two most common risk factors. Making the diagnosis can be complex and often requires the use of Computed Tomography and angiography. The later adds the advantage of being a therapeutic option to prevent or stop bleeding. If this fails, surgery is still regarded as the standard for accomplishing a definite treatment.

1 January 2012
Verified
Closed access
GAGeorges Abourjaili
Georges Abourjaili
ETEstelle Torbey
Estelle Torbey
TATaher Alsaghir
Taher Alsaghir
YOYefim Olkovski
Yefim Olkovski
TCThomas Costantino
Thomas Costantino

Verified
Journal Article
Open access
PDF file
KTkamala tamirisa
kamala tamirisa
JIJorge Irizarry-Caro
Jorge Irizarry-Caro
ICIan Curnutt
Ian Curnutt
DADevika Adusumilli
Devika Adusumilli
MJMia Jose
Mia Jose
AVAnnabelle Santos Volgman
Annabelle Santos Volgman
Autoimmune diseases substantially increase the risk of atrial and ventricular arrhythmias and sudden cardiac death through shared immune-mediated mechanisms. Pro-inflammatory cytokines, autoantibodies, and progressive myocardial fibrosis disrupt ion channel function, impair conduction, and create re-entrant substrates. Across systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (SSc), these pathways manifest as atrial fibrillation, ventricular arrhythmias, conduction disease, and heightened arrhythmic mortality. Anti Ro/SSA antibodies, in particular, contribute to QT prolongation and atrioventricular (AV) block, while cytokines such as TNF α, IL 1β, and IL 6 remodel electrophysiological properties and promote fibrosis. Advanced cardiac imaging, especially cardiac magnetic resonance (CMR), detects inflammation and fibrosis even when ejection fraction is preserved, enabling earlier intervention. Management requires a dual approach: standard arrhythmia therapies alongside aggressive control of systemic inflammation with disease-specific immunosuppression. Despite growing evidence, major gaps remain, including the absence of randomized trials targeting immune-driven arrhythmias and the need for integrated risk models incorporating inflammatory biomarkers.